Doreen Moraa Muracha is one of the top HIV educationalist and a top researcher in Kenya. Doreen has lived with HIV for twenty nine years. Doreen was actually born with HIV and only came to know she was positive after eight years of getting sick.
Doreen loves to create awareness about HIV latest news and developments and she loves encouraging people living with HIV to adhere to the drugs. Doreen always advocates that adherence to ARVs is equals to living undetectable. Doreen says that undetectable queens and Kings hardly transmit HIV virus to other people and that it helps one to live healthy without becoming a culprit of HIV opportunistic infections.
Today fans have enquired if there is hope for having HIV Cure very soon from Doreen because taking ARVS on daily basis is no joke. Doreen has said that for Cure yet more research is to be done but there is hope of Injectable ARVs Which is currently on trial on different parts of the world.
Content created and supplied by: Ravera (via Opera News )
Opera News is a free to use platform and the views and opinions expressed herein are solely those of the author and do not represent, reflect or express the views of Opera News. Any/all written content and images displayed are provided by the blogger/author, appear herein as submitted by the blogger/author and are unedited by Opera News. Opera News does not consent to nor does it condone the posting of any content that violates the rights (including the copyrights) of any third party, nor content that may malign, inter alia, any religion, ethnic group, organization, gender, company, or individual. Opera News furthermore does not condone the use of our platform for the purposes encouraging/endorsing hate speech, violation of human rights and/or utterances of a defamatory nature. If the content contained herein violates any of your rights, including those of copyright, and/or violates any the above mentioned factors, you are requested to immediately notify us using via the following email address operanews-external(at)opera.com and/or report the article using the available reporting functionality built into our Platform See More